Angiotensin II has multiple profibrotic effects in human cardiac fibroblasts.
about
Epigenetic regulation in cardiac fibrosisRegulators of G-protein signaling in the heart and their potential as therapeutic targets.Endothelial dysfunction: a comprehensive appraisal.Identification of differentially expressed genes induced by angiotensin II in rat cardiac fibroblastsAngiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathyTetrahydrobiopterin attenuates cholesterol induced coronary hyperreactivity to endothelin.ANG II increases TIMP-1 expression in rat aortic smooth muscle cells in vivoAcute kidney injury in the rat causes cardiac remodelling and increases angiotensin-converting enzyme 2 expressionPercutaneous aortic valve replacement: will we get there?Contrast enhanced magnetic resonance angiography and pulmonary venous anomaliesReciprocal increase of circulating interleukin-10 and interleukin-6 in patients with acute myocardial infarction.Effects of cardiac resynchronisation on maximal and submaximal exercise performance in advanced heart failure patients with conduction abnormality.Idiopathic dilated cardiomyopathy: lack of association with haemochromatosis gene in the CARDIGENE studyTransforming growth factor-beta(1) expression in dilated cardiomyopathyHigh molecular weight fibroblast growth factor-2 in the human heart is a potential target for prevention of cardiac remodelingEffects of serum containing Xinlikang on angiotensin ii induced hypertrophy in cultured neonatal rat cardiomyocytes.Piperine Attenuates Pathological Cardiac Fibrosis Via PPAR-γ/AKT Pathways.Inhibition of cardiac myofibroblast formation and collagen synthesis by activation and overexpression of adenylyl cyclase.Angiotensin-(1-7) and angiotensin Ⅱ induce the transdifferentiation of human endometrial epithelial cells in vitro.Evaluation of cardiovascular risk factors in women with uterine leimyoma: is there a link with atherosclerosis?Novel therapy in the treatment of scleroderma.Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current statusThe renin-angiotensin-aldosterone system and vascular remodeling.Angiotensin II type 1 receptor antagonist attenuates lacrimal gland, lung, and liver fibrosis in a murine model of chronic graft-versus-host diseaseAngiotensin-converting enzyme 2 activation protects against hypertension-induced cardiac fibrosis involving extracellular signal-regulated kinases.Regulator of G protein signaling 2 is a functionally important negative regulator of angiotensin II-induced cardiac fibroblast responses.New directions in strategies using cell therapy for heart disease.Angiotensin II receptor blockers improve peripheral endothelial function: a meta-analysis of randomized controlled trials.CCR2 mediates the uptake of bone marrow-derived fibroblast precursors in angiotensin II-induced cardiac fibrosis.Vitronectin-binding PAI-1 protects against the development of cardiac fibrosis through interaction with fibroblastsReduced cardiac expression of plasminogen activator inhibitor 1 and transforming growth factor beta1 in obese Zucker rats by perindopril.Role of angiotensin AT1 and AT2 receptors in cardiac hypertrophy and cardiac remodelling.Can natriuretic peptides be used for the diagnosis of diastolic heart failure?Combined effects of aging and inflammation on renin-angiotensin system mediate mitochondrial dysfunction and phenotypic changes in cardiomyopathies.Protective effect of Sheng-Mai Yin, a traditional Chinese preparation, against doxorubicin-induced cardiac toxicity in rats.Effect of angiotensin-(1-7) and angiotensin II on the proliferation and activation of human endometrial stromal cells in vitroDisruptions and detours in the myocardial matrix highway and heart failure.International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected].Iron-overload injury and cardiomyopathy in acquired and genetic models is attenuated by resveratrol therapy.Cardiac fibroblasts: friend or foe?
P2860
Q26774536-AB9442C4-CDF9-45F5-B295-5158AF60C0E4Q27686777-3A08425E-B8B1-400D-8CED-383264217F74Q28195411-8FD410FE-0EF4-4A1F-8276-9E8ADF9321CBQ28294488-BCB4CC99-3336-4D70-A7FA-180013932CFEQ28348531-7252C7C5-B902-40FB-BD71-0A1FB1D8F771Q28364296-98DCF862-5858-4C74-93C6-029443BC0F04Q28565557-310812F5-D5CE-4C2B-8182-A9049CFDDE9DQ28583180-E57FEB15-3243-4D27-8F3E-51B67A347858Q30444798-3C3F8FED-74AC-4F07-9A42-697CCF533469Q30444802-A727A80D-AC9F-436C-9544-9EEE1AB0E19BQ30444805-3C18D39E-E124-4729-ADBC-ABDA64E2C947Q30444807-0ABE25B6-E85A-4258-A7AC-0D3C159AC104Q30444810-ECE82AB8-5003-4053-B0FA-95ED3817A1C7Q30444812-BAB47BB3-6B39-499B-BD1D-D552E5F13F84Q31161236-48C9DA08-ED1B-4E0E-B14A-0BC7620F5ECCQ33258604-53E3BC34-CF65-4D96-9C39-47CD7A209E9BQ33603596-B296B994-A795-494E-824C-0D6E1CBB913EQ33723868-94C56325-8176-40C2-9DCE-A58E907CA7BEQ33747833-E4C1CC44-4FF6-4A3D-B3CE-FC29D7D669C6Q33973446-021BBDD4-6B64-414C-930E-C8FC01356510Q34104580-30E36256-73AC-4B17-9F58-AA194EE8D517Q34124779-3AD52E77-BEF6-451E-8DBB-B941953EAEDBQ34513169-F7D9C821-E9DA-4C9C-9395-1C988CD33C1CQ34769458-216D6713-3671-4576-AAFB-7B617CF70247Q34799585-F99921A6-FFC0-46E0-8B2A-5FEE9ED0B4D1Q35087035-E9CBCB66-60B4-49ED-B709-2FCBA3F218FBQ35108283-74AE1AB6-5007-4DFA-B3B3-1CC50E824850Q35111064-4712F8F1-5A9B-4A5D-B921-8F1F22B84FE2Q35159918-923D0499-4376-42DD-9E7E-CABCBFAAC00CQ35180538-F73C0CE8-97B1-4B1A-A71F-BFE6BF582296Q35583438-11B6FF77-47D1-43A4-A350-3AA530A6727FQ35608848-CDCA939B-512B-429E-8691-A999C37EF826Q35677306-F8224612-EB90-4FE2-B25E-D1AD1315DD17Q35828486-63A0AC34-4C64-410F-B50E-7B1C2F55032CQ35920346-2392966E-1AB9-4B42-B8C8-B08AD9073C5AQ36095097-BF067FBC-5D87-4E04-BA1A-AB0C5AEF8068Q36203117-9CB24724-0B50-40D4-8A68-5894F696E036Q36241932-C8B766CF-C3AB-42AB-9776-730494F5FAADQ36350590-E4E16E61-E14B-45D8-8FCA-79A9771018C0Q36450335-AB8F4F48-8862-4B8F-9F56-610B63E08FAB
P2860
Angiotensin II has multiple profibrotic effects in human cardiac fibroblasts.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Angiotensin II has multiple profibrotic effects in human cardiac fibroblasts.
@en
type
label
Angiotensin II has multiple profibrotic effects in human cardiac fibroblasts.
@en
prefLabel
Angiotensin II has multiple profibrotic effects in human cardiac fibroblasts.
@en
P2093
P1433
P1476
Angiotensin II has multiple profibrotic effects in human cardiac fibroblasts.
@en
P2093
P304
P356
10.1161/01.CIR.101.10.1130
P407
P577
2000-03-01T00:00:00Z